Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance

Targeted monoclonal antibody therapy has emerged as a powerful therapeutic strategy for cancer. However, only a minority of patients have durable responses and the development of resistance remains a major clinical obstacle. Antibody-dependent cell-mediated cytotoxicity (ADCC) represents a crucial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahavi, David J., Erbe, Rossin, Zhang, Yong-Wei, Guo, Theresa, Malchiodi, Zoe X., Maynard, Rachael, Lekan, Alexander, Gallagher, Rosa, Wulfkuhle, Julia, Petricoin, Emanuel, Jablonski, Sandra A., Fertig, Elana J., Weiner, Louis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601508/
https://www.ncbi.nlm.nih.gov/pubmed/37878417
http://dx.doi.org/10.1080/15384047.2023.2269637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601508/
https://www.ncbi.nlm.nih.gov/pubmed/37878417
http://dx.doi.org/10.1080/15384047.2023.2269637

Ejemplares similares